Research Notes on Azilect Slows Progression of Parkinson's Disease
Teva Pharmaceutical Industries has introduced a new drug called Azilect (rasagiline) which has been shown to slow the progression of Parkinson's disease. This devastating brain disorder causes memory loss, hallucinations and body shakes. It is estimated that 4 million people worldwide suffer from Parkinson's.
Top Resources on Azilect Slows Progression of Parkinson's Disease
- MarketWatch: ADAGIO Trial Results Show Teva's AZILECT(R) 1 mg Tablets Slow Progression of Parkinson's Disease (Aug. 26, 2008)
- Forbes: Teva Says Azilect Slows Progression of Parkinson's (Aug. 26, 2008)
- Reuters: Teva Says Study Shows Azilect Slows Parkinson's (Aug. 26, 2008)
- eFluxMedia: New Drug Slows the Progression of Parkinson’s (Aug. 26, 2008)
- Bloomberg: Teva Says Parkinson's Drug Is First to Slow Disease (Aug. 26, 2008)
5 Latest Headlines on Azilect Slows Progression of Parkinson's Disease
User Recommended Links for Azilect Slows Progression of Parkinson's Disease
Are we missing any great links? Please Login or Register to be the first to add to this list of recommended links to help others and improve this WisdomCard.
About this WisdomCard
- Contributor: Amy Sandhu
- Reviewer: Nicole Kinsey
- Supervised by: The OrganizedWisdom Physician Review Team
- Last update: Nov. 10, 2008
Each WisdomCard is handcrafted by our team of physician-guided health advocates. Our goal is to make it easy for you to find the most useful health resources for any health topic. In addition to filtering out spam and bad links, WisdomCards highlight tips and warnings, such as:
- Guide Favorite
- Guide Warning
- Scroll down to reach relevant content
- Video
- In Memoriam
Help improve this WisdomCard by suggesting great links.
